National Cancer Institute
Found 923 results for your search:
Total relevant funding to Leukemia for this search:
$234,716,347
Fiscal Year FY 2012
Cancer Type [Leukemia]
Modify this Search New Search
Close

Modify Search Criteria

Some search criteria may be modified to refine your current search.

Select criteria to modify:

Add or remove search options:

Select criteria above to see additional search options

Cancel
Showing 1 - 50 of 923 results
Clipboard
Project Title Sorted ascending Project Number Funded Amount
Relevant Funding
Principal
Investigator
Institution
1
"BCR/ABL-PI-3k-ROS pathway induce genomic instability ...." 5R01CA134458-03 $307,951 $307,951 SKORSKI, TOMASZ TEMPLE UNIVERSITY
2
"Oncorequisite" Genes in MYC-mediated Transformation 4R00CA134743-03 $233,147 $186,518 FENG, HUI BOSTON UNIVERSITY MEDICAL CAMPUS
3
24th Annual Fanconi Anemia Research Fund Scientific Symposium 1R13CA171695-01 $1 $1 Bagby, Grover FANCONI ANEMIA RESEARCH FUND, INC.
4
5-hydroxymethylcytosine in human cancer 1R01CA160965-01A1 $348,600 $174,300 Pfeifer, Gerd CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
5
???Novel melampomagnolide B-based prodrugs for the treatment of leukemia??? 5R01CA158275-03 $313,325 $313,325 Crooks, Peter UNIVERSITY OF ARKANSAS MED SCIS LTL ROCK
6
A cohort study among workers exposed to benzene in China ZIA CP010120-02060 $354,811 $141,924 Rothman, Nat DCEG (NCI)
7
A CROSS-SECTIONAL STUDY OF OCCUPATIONAL EXPOSURE TO TRICHLOROETHYLENE, CHROMOSOMAL ABERRATIONS, AND ZIA CP010121-10363 $35,570 $35,570 Lan, Qing DCEG (NCI)
8
A Flexible and Concise Approach to the Citrinadins: Total Synthesis of Citrinadin 1F32CA167908-01 $47,114 $23,557 Mundal, Devon UNIVERSITY OF CALIFORNIA BERKELEY
9
A Novel Modulator of Notch in Acute Lymphoblastic Leukemia 5R21CA161436-02 $176,175 $176,175 Liang, Chengyu UNIVERSITY OF SOUTHERN CALIFORNIA
10
A Novel sequencing-based approach to discovering rare genetic factors for ALL. 5K08CA140720-03 $149,387 $149,387 Druley, Todd WASHINGTON UNIVERSITY
11
A Patient Centered Approach to Enrolling Rare Cancer Patients in Clinical Trials 2R44CA144362-02A1 $689,294 $172,324 Wiener, Matthew PHARMATECH, INC.
12
A Phase II proof-of-concept trial to study kinase inhibition in relapsed/refracto 5R21CA159265-02 $272,667 $272,667 LORIAUX, MARC OREGON HEALTH AND SCIENCE UNIVERSITY
13
A Pilot Study of Decitabine and Vorinostat with Chemotherapy for Relapsed ALL 5R21CA161688-02 $321,931 $321,931 Burke, Michael UNIVERSITY OF MINNESOTA
14
A role for elevated autophagy in survival and chemoresistance of leukemia stem ce 1R21CA158728-01A1 $220,545 $220,545 Guzman, Monica WEILL MEDICAL COLLEGE OF CORNELL UNIV
15
A Role for KSHV in the Pathogenesis of Malignancies ZIASC010356 $343,957 $34,396 Tosato, Giovanna CCR (NCI)
16
A Role for PML in Genome Stability and DNA Damage Response 5R01CA055577-19 $256,139 $204,911 CHANG, KUN-SANG UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
17
A Universal Approach to Personalized Adoptive T cell Therapy of Cancer 1R01CA168900-01 $332,000 $166,000 Powell, Daniel UNIVERSITY OF PENNSYLVANIA
18
AARP prospective study of diet and cancer ZIA CP010196-03152 $1,258,475 $62,924 Sinha, Rashmi DCEG (NCI)
19
Aberrant activation of HGF/MET signaling as a therapeutic target in AML 5K08CA160660-02 $156,330 $156,330 Kentsis, Alex DANA-FARBER CANCER INSTITUTE
20
Abramson Cancer Center Support Grant 5P30CA016520-36 $7,725,062 $463,504 DANG, CHI UNIVERSITY OF PENNSYLVANIA
21
Activation of Proto-Oncogenes by Chromosomal Translocation ZIASC010378 $441,016 $220,508 Aplan, Peter CCR (NCI)
22
Adoptive Immunotherapy of Cancer with IL-12 Secreting Tumor-Targeted T cells 5R01CA138738-04 $381,617 $190,809 Brentjens, Renier SLOAN-KETTERING INSTITUTE FOR CANCER RES
23
Adult Leukemia Research Center 2P01CA018029-37A1 $4,225,448 $3,422,613 APPELBAUM, FREDERICK FRED HUTCHINSON CANCER RESEARCH CENTER
24
Agricultural Health Study - Biomarkers of Exposures and Effects in Agriculture ZIA CP010119-10527 $441,719 $220,860 Alavanja, Michael DCEG (NCI)
25
AID-mediated genetic instability in BCR-ABL1-transformed B cell lineage leukemia 5R01CA139032-04 $322,040 $322,040 Muschen, Markus CHILDREN'S HOSPITAL LOS ANGELES
26
ALL therapy and developing brains: MRI measures, genetic factors and cognition 5R01CA090246-07 $380,224 $380,224 REDDICK, WILBURN ST. JUDE CHILDREN'S RESEARCH HOSPITAL
27
Allogeneic stem cell transplant with grafts depleted of naive T cells for leukemi 5K23CA154532-02 $170,100 $170,100 Bleakley, Marie FRED HUTCHINSON CANCER RESEARCH CENTER
28
Allogeneic T cells Transduced with an Anti-CD19 Chimeric Antigen Receptor ZIABC011415 $30,333 $20,323 Kochenderfer, James CCR (NCI)
29
Alloreactive Regulatory T cells control GVHD and maintain GVL effect 5R01CA118116-05 $291,425 $291,425 YU, XUE-ZHONG H. LEE MOFFITT CANCER CTR & RES INST
30
Allosteric Inhibitor Discovery Technology for Protein Kinases 1R21CA169962-01 $165,844 $165,844 SMITHGALL, THOMAS UNIVERSITY OF PITTSBURGH AT PITTSBURGH
31
Alternative RNA splicing and protein products in leukemia outcome (PQ11) 1R01CA170250-01 $594,337 $594,337 NESS, SCOTT UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR
32
Amplifying Radiation Potency Against Leukemic Stem Cells 1R21CA164098-01 $211,410 $211,410 UCKUN, FATIH CHILDREN'S HOSPITAL LOS ANGELES
33
Analysis of higher order chromatin structures in normal and cancer epigenomes 5R01CA140485-03 $333,111 $333,111 Kim, Tae Hoon YALE UNIVERSITY
34
Analysis of the leukemic stem cell niche in chronic myeloid leukemia 5K08CA138916-03 $162,568 $162,568 Krause, Daniela MASSACHUSETTS GENERAL HOSPITAL
35
Anatomic Pathology Residency Program ZIEBC011384 $1,082,541 $54,127 Oberholtzer, John CCR (NCI)
36
Animal models to study the role of INK4b loss in human acute myeloid leukemia ZIABC011027 $687,814 $687,814 Wolff, Linda CCR (NCI)
37
Antibody Engineering for Therapy and Diagnosis of Hematologic Malignancies ZIABC010647 $297,122 $148,561 Rader, Christoph CCR (NCI)
38
Antibody V Gene Expression B Cell Lymphocytic Leukemia 5R37CA049870-25 $318,906 $318,906 KIPPS, THOMAS UNIVERSITY OF CALIFORNIA AT SAN DIEGO
39
Antitumor-Antibiotics from Marine Microorganisms 3R37CA044848-26S1 $77,500 $31,000 FENICAL, WILLIAM UNIVERSITY OF CALIFORNIA AT SAN DIEGO
40
Antitumor-Antibiotics from Marine Microorganisms 5R37CA044848-26 $373,010 $149,204 FENICAL, WILLIAM UNIVERSITY OF CALIFORNIA AT SAN DIEGO
41
Apoptosis Induced by Glucocorticoids and MEK1/2 Inhibitors in Leukemia 5R01CA134473-04 $237,412 $237,412 HARADA, HISASHI VIRGINIA COMMONWEALTH UNIVERSITY
42
Aptamer Based Technology for Molecular Analysis of Leukemia 5R01CA129311-05 $294,868 $294,868 Li, Ying UNIVERSITY OF FLORIDA
43
Arizona Cancer Center-Cancer Center Support Grant 3P30CA023074-34S1 $75,000 $1,500 Alberts, David UNIVERSITY OF ARIZONA
44
Arizona Cancer Center-Cancer Center Support Grant 3P30CA023074-34S2 $143,846 $2,877 Alberts, David UNIVERSITY OF ARIZONA
45
Arizona Cancer Center-Cancer Center Support Grant 5P30CA023074-34 $3,953,813 $79,076 Alberts, David UNIVERSITY OF ARIZONA
46
Arsenic Trioxide activated pathways in malignant cells 2R01CA121192-06 $266,285 $266,285 PLATANIAS, LEONIDAS NORTHWESTERN UNIVERSITY AT CHICAGO
47
Arsenic Trioxide and Acute Myeloid Leukemia 5R01CA093533-09 $247,445 $247,445 JING, YONGKUI MOUNT SINAI SCHOOL OF MEDICINE
48
Assays for Screening Histone Modifications in Cancer 5R01CA107106-07 $226,740 $226,740 FREITAS, MICHAEL OHIO STATE UNIVERSITY
49
ATBC Study ZIA CP010195-03031 $1,176,890 $35,307 Albanes, Demetrius DCEG (NCI)
50
Augmenting Antitumor Immunity after Allografting 5R01CA122779-05 $295,461 $295,461 LUZNIK, LEO JOHNS HOPKINS UNIVERSITY
Total relevant funding to Leukemia for this search: $234,716,347
Showing 1 - 50 of 923 results
Go to top